Open AccessEfficiency and safety of the modified protocol for cardioversion of atrial fibrillation using domestic antiarrhythmic drug Refralon. Initial clinical results
Author(s) -
Х. М. Дзаурова,
N. Yu. Mironov,
Yuri V. Shubik,
Vladislav Vlodzyanovsky,
Diana Gagloeva,
Lada Yu. Laiovich,
Т. А. Малкина,
Л. В. Зинченко,
С. Ф. Соколов,
S P Golitsyn
Publication year - 2021
Publication title -
kardiologičeskij vestnik
Language(s) - English
Resource type - Journals
eISSN - 2712-889X
pISSN - 2077-6764
DOI - 10.17116/cardiobulletin20211601149
Subject(s) - atrial fibrillation , cardioversion , medicine , electrical cardioversion , cardiology , drug , pharmacology